Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Korea Stock Exchange  >  Celltrion, Inc.    A068270   KR7068270008

CELLTRION, INC.

(A068270)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Celltrion, Inc. is a Korea-based company mainly engaged in the production and sale of biopharmaceuticals. Along with subsidiaries, the Company operates its business through three segments. The Biopharmaceutical segment is involved in the manufacturing and sale of biopharmaceutical products such as multivitamins, blood circulation remedies, blood cancer treatments and breast cancer treatments. The Chemical Pharmaceutical segment is involved in the manufacturing and sale of therapeutic drugs for liver disease under the name of Godex, as well as the treatment of autoimmune diseases under the name of Remsima. The Other segment manufactures and sells other generic drugs. The Company distributes its products within the domestic market and to overseas markets.

Number of employees : 2 111 people.
Sales per Business
20182019Delta
KRW (in Million)%KRW (in Million)%
Biopharmaceuticals861,88487.8%981,87087% +13.92%
Chemical Drugs139,47114.2%172,68315.3% +23.81%
Other7,7010.8%4,2710.4% -44.54%
Sales per region
20182019Delta
KRW (in Million)%KRW (in Million)%
South Korea890,68690.7%1,017,47090.2% +14.23%
Overseas91,3899.3%110,9889.8% +21.45%
Managers
NameAgeSinceTitle
Wu-Sung Ki58-Chief Executive Officer & Director
Jung-Jin Seo63-Chairman
Ho-Seop Lee44-Finance Director
Dong-Il Kim, Dr.622008Independent Director
Joseph Lee622008Independent Director
Gyun-Seok Cho612009Independent Director
Byung-Hoon Jeon632014Independent Director
Jong-Seok Lee, Dr.682014Independent Director
Geun-Young Kim60-Independent Director
Won-Seok Kim55-Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 134,997,805 92,245,967 68.3% 1,212,915 0.9% 68.3%
Shareholders
NameEquities%
Jung-Jin Seo 29,884,606 22.1%
National Pension Service of Korea 12,363,020 9.16%
Temasek Holdings Pte Ltd. (Investment Management) 10,100,468 7.48%
The Vanguard Group, Inc. 3,017,396 2.24%
BlackRock Fund Advisors 2,105,390 1.56%
Baillie Gifford & Co. 1,810,384 1.34%
Celltrion, Inc. 1,188,159 0.88%
Norges Bank Investment Management 1,183,627 0.88%
Mirae Asset Global Investments Co., Ltd. 983,076 0.73%
Celltrion Inc. Employee Stock Ownership ASSN. 765,634 0.57%
Holdings
NameEquities%Valuation
Celltrion Pharm Inc (A068760) 19,682,19055.0%1,887,214,388 USD
Celltrion, Inc. (A068270) 1,188,1590.88%252,354,207 USD
Biotoxtech Co Ltd (A086040) 1,631,13411.2%15,237,532 USD
Company contact information
Celltrion, Inc.
23 Academy-ro
Yeonsu-gu
Inchon, Incheon 22014

Phone : +82.32.850.5000
Fax : +82.32.850.5040
Web : http://www.celltrion.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
CELLTRION, INC.87.85%41 539
MODERNA, INC.620.91%60 441
LONZA GROUP AG61.27%46 692
IQVIA HOLDINGS INC.9.37%32 400
SEAGEN INC.55.27%30 708
IMMUNOMEDICS, INC.315.22%20 324
INCYTE CORPORATION-3.18%18 514
ALNYLAM PHARMACEUTICALS, INC.14.85%15 093
HANGZHOU TIGERMED CONSULTING CO.,LTD80.52%15 061
PPD, INC.0.00%12 238
BIO-TECHNE CORPORATION38.92%11 711
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.50.67%11 666
PHARMARON BEIJING CO., LTD.81.61%11 024
QIAGEN N.V.42.78%11 009
ICON PUBLIC LIMITED COMPANY14.64%10 285
ACADIA PHARMACEUTICALS INC.32.75%9 008
CRISPR THERAPEUTICS AG108.39%8 967
GALAPAGOS NV-43.51%8 055
PRA HEALTH SCIENCES, INC.0.94%7 198
NOVAVAX, INC.3,405.03%7 134
IONIS PHARMACEUTICALS, INC.-15.38%7 065